P.-M. Roger

1.2k citations

32 papers · 563 indexed · h-index 11

Behavioral Neuroscience top 5%
Applied Microbiology and Biotechnology top 2%
- Antibiotic Use and Resistance 4
Biological Psychiatry top 5%
Infectious Diseases
- HIV/AIDS drug development and treatment 3
- Antifungal resistance and susceptibility 3
Social Psychology top 10%
Organic Chemistry
- Carbohydrate Chemistry and Synthesis 7
Virology
- HIV Research and Treatment 3
Epidemiology
- Pneumonia and Respiratory Infections 3
General Health Professions
- Healthcare Systems and Practices 3
- Health, Medicine and Society 2

Co-authors: Michel Geslin Philippe Soubrié R. Steinberg M. Jung Jean‐Pierre Maffrand Guy Griebel B. Scatton Danielle Gully
Cited by: Behavioral Neuroscience Applied Microbiology and Biotechnology Biological Psychiatry
Journals: Tetrahedron Letters (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
Partner nations: France Belgium United States

In The Last Decade

P.-M. Roger

31 papers receiving 546 citations

Peers

Countries citing papers authored by P.-M. Roger

Since Specialization

Citations

This map shows the geographic impact of P.-M. Roger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.-M. Roger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.-M. Roger more than expected).

Fields of papers citing papers by P.-M. Roger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.-M. Roger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.-M. Roger. The network helps show where P.-M. Roger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P.-M. Roger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P.-M. Roger Line = papers co-authored together P.-M. Roger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients Infectious Diseases ·Clotilde Allavena,Christine Katlama,Laurent Cotte,P.-M. Roger,Pierre Delobel,Antoine Chéret,Claudine Duvivier,Isabelle Poizot‐Martin,Bruno Hoën,André Cabié,Arnaud Chéret,Márcia da do Silva,F. Raffi,Pascal Puglièse,(unknown)	2016	5
2	Early infectious acute respiratory distress syndrome is characterized by activation and proliferation of alveolar T-cells European Journal of Clinical Microbiology & Infectious Diseases ·Karine Risso,Gaurav Kumar,Michel Ticchioni,C. Sanfiorenzo,Jean Dellamonica,Mercedes Rivas-Cascallar,Gilles Bernardin,Charles‐Hugo Marquette,P.-M. Roger	2015	34
3	Factors associated with effective reassessment of antibiotic therapy on day 3 Médecine et Maladies Infectieuses ·P.-M. Roger,H. Nitzsche,ida setya rinati,邵家琦,Luca Valerio,Sedat Aybars Nazlica,Tai-Heon Yoon,Nicolas Bèle,هــالة أحمـــد الرشيـــدى	2013	6
4	Increased Time Exposure to Tenofovir Is Associated with a Greater Decrease in Estimated Glomerular Filtration Rate in HIV Patients with Kidney Function of Less than 60 ml/min/1.73 m<sup>2</sup> Nephron Clinical Practice ·DeLana Leonard,P. Puglièse,J. Durant,V. Mondain,馨子前田,E. Della Morte,Nyaga Elkana Kathie,I. Perbost,哲史岡部,P.-M. Roger,Éric Cua,P. Dellamonica,Vincent Esnault,Christian Pradier,Olivier Moranne	2012	14
5	Possible pandemic HIN1 influenza complicated by Pneumocystis jirovecii pneumonia in an HIV-infected patient Journal de Mycologie Médicale ·C. Pulcini,Lilia Hasseine,V. Mondain,G. Baudin,P.-M. Roger	2012	5
6	T-08 Réévaluation de l’antibiothérapie à 48-72 heures (R-ATB) à l’échelle d’un Centre Hospitalier Régional Médecine et Maladies Infectieuses ·P.-M. Roger,هــالة أحمـــد الرشيـــدى,Jason Ginn,邵家琦,H. Nitzsche	2009	1
7	Gestion de services, tarification à l’activité, recherche clinique et évaluation des pratiques professionnelles : un même outil informatique Médecine et Maladies Infectieuses ·P.-M. Roger,Yuhang Wu,Stéphanie Leroux,Jenny Scheffers,Ja-rang Lee,Khayetbek Gayratjon Ugli Olimov,Éric Cua	2008	15
8	Antibiotic misuse: a prospective clinical audit in a French university hospital European Journal of Clinical Microbiology & Infectious Diseases ·C. Pulcini,Éric Cua,F. Lieutier,Luce Landraud,P. Dellamonica,P.-M. Roger	2007	73
9	In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides Journal of Antimicrobial Chemotherapy ·Gustav Larson,Marc Galimand,F. Vandenbos,Christian Pradier,P.-M. Roger,Brigitte Dunais,B. Fagerlund,Syed Muhammad Tariq,P. Dellamonica	2005	10
10	Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions Journal of Antimicrobial Chemotherapy ·P.-M. Roger	2003	2
11	4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders Journal of Pharmacology and Experimental Therapeutics ·Guy Griebel,Jacques Simiand,R. Steinberg,M. Jung,Danielle Gully,P.-M. Roger,Michel Geslin,B. Scatton,Jean‐Pierre Maffrand,Philippe Soubrié	2002	197
12	How to organise antibiotic prescription International Journal of Antimicrobial Agents ·P. Dellamonica,P.-M. Roger,Nicholas Alen Chmielewski,信幸市川,E Bernard,Mariele da Cruz	2001	5
13	Longterm Survival in Acute Rhinocerebral Mucormycosis with Giant Cell Arteritis and Foreign Body Granulomas Pathology - Research and Practice ·L. Castillo,Véronique Hofman,Manuel Montero Macarro,J.G. Maguire,P.-M. Roger,Josef Štaif,Paul Hofman	2001	13
14	Medical Treatment of a Pacemaker Endocarditis due to Candida albicans and to Candida glabrata Journal of Infection ·P.-M. Roger,Jin-Tao Gao,M. Gari-Toussaint,Dominique Cenon,V. Mondain,(unknown),Y. Le Fichoux,J Michiels,P. Dellamonica	2000	19
15	Synthesis of 6-Hydroxy-L-Daunosamine and L-Daunosamine Derivatives Journal of Carbohydrate Chemistry ·Bo-ra Koh,P.-M. Roger,Claude Monneret	1997	12
16	Chemical stability of ecomustine, a new antitumor agent in aqueous and biological media as assessed by high-performance liquid chromatography Cancer Chemotherapy and Pharmacology ·Guobiao Gao,P.-M. Roger,Charles Gosse,Ghanem Atassi,Alain Gouyette	1991	1
17	Synthesis of 3′-azido-5′-homothymidine analogs Tetrahedron Letters ·Esmeralda Rizzo,Shishr Gupta,Claude Monneret,P.-M. Roger	1991	7
18	Synthese du methyl [(chloro‐2 ethyl)‐3 nitroso‐3 ureido]‐3 didesoxy‐2, 3 α‐D‐arabino‐hexopyrannoside marque AU carbone‐14 OU ⁻AU carbone‐13 (CY 233 ‐ SR 90098) Journal of Labelled Compounds and Radiopharmaceuticals ·SANG-PIL LEE,V. Acharya,Daniel Galán Rello,Alain Gouyette,Michel Geslin,Jean Fournier,Yves Berger,P.-M. Roger	1990	2
19	Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars Journal of Medicinal Chemistry ·P.-M. Roger,Claude Monneret,Jean Fournier,Zhi-Ming Zhang,Jørgen A. Arnesen,Charles Gosse,Yves Letourneux,Ghanem Atassi,Alain Gouyette	1989	57
20	Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233 Cancer Chemotherapy and Pharmacology ·Ghanem Atassi,Patrick Dumont,Charlie Gosse,Jean Fournier,Alain Gouyette,P.-M. Roger	1989	6

About P.-M. Roger

P.-M. Roger is a scholar working on Applied Microbiology and Biotechnology, Virology and Family Practice, having authored 32 papers that have together received 563 indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (7 papers), Antibiotic Use and Resistance (4 papers), HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (3 papers), Pneumonia and Respiratory Infections (3 papers), Antifungal resistance and susceptibility (3 papers), Healthcare Systems and Practices (3 papers) and Health, Medicine and Society (2 papers). The work is most often cited by research in Behavioral Neuroscience (163 citations), Applied Microbiology and Biotechnology (78 citations) and Biological Psychiatry (86 citations). P.-M. Roger has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Michel Geslin, Philippe Soubrié, R. Steinberg, M. Jung, Jean‐Pierre Maffrand, Guy Griebel, B. Scatton, Danielle Gully, Jacques Simiand and P. Dellamonica. Their work appears in journals such as Tetrahedron Letters, Cancer Chemotherapy and Pharmacology, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact